Shareholder's Equity (Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share) (Details) (USD $) In Thousands, except Share data, unless otherwise specified	3 Months Ended		9 Months Ended
	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (Numerator)	$ (10,704)	$ 16,659	$ 25,569	$ 52,192
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (basic), shares (Denominator)	46,320,000	31,376,000	36,620,000	31,267,000
Effect of dilutive securities options and non-vested shares	0	615,000	406,000	645,000
Net earnings (loss) from continuing operations attributable to AmSurg Corp. (diluted), shares (Denominator)	46,320,000	31,991,000	37,026,000	31,912,000
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (basic), (usd per share)	$ (0.23)	$ 0.53	$ 0.70	$ 1.67
Net earnings (loss) from continuing operations attributable to AmSurg Corp. common shareholders (diluted), (usd per share)	$ (0.23)	$ 0.52	$ 0.69	$ 1.64
Mandatory Convertible Preferred Stock [Member]
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Number of anti-dilutive shares	3,400,000		3,400,000